References
- PflugfelderSCPrevalence, burden, and pharmacoeconomics of dry eye diseaseAm J Manag Care2008143 SupplS102S10618452369
- YamadaMDry eye syndrome: concept, pathogenesis, and therapeutic modalities based on the new definitionJ Jpn Ophthalmol Soc2008113541552
- SchiffmanRMChristiansonMDJacobsenGHirschJDReisBLReliability and validity of the Ocular Surface Disease IndexArch Ophthalmol200011861562110815152
- MertzanisPAbetzLRajagopalanKThe relative burden of dry eye in patients’ lives: comparisons to a US normative sampleInvest Ophthalmol Vis Sci200546465015623753
- MizunoYYamadaMMiyakeYAssociation between clinical diagnostic tests and health-related quality of life surveys in patients with dry eye syndromeJpn J Ophthalmol20105425926520700790
- MiljanovicBDanaRSullivanDASchaumbergDAImpact of dry eye syndrome on vision-related quality of lifeAm J Ophthalmol200714340941517317388
- SchiffmanRMWaltJGJacobsenGDoyleJJLebovicsGSumnerWUtility assessment among patients with dry eye diseaseOphthalmology20031101412141912867401
- CleggJPGuestJFLehmanASmithAFThe annual cost of dry eye syndrome in France, Germany, Italy, Spain, Sweden and the United Kingdom among patients managed by ophthalmologistsOphthalmic Epidemiol20061326327416877285
- EnzenauerRWKaoAWilliamsTLambertRWRelative costs of various preserved artificial tear solutions for the treatment of dry eye conditionsEye Contact Lens20032923824014555900
- ReddyPGradORajagopalanKThe economic burden of dry eye: a conceptual framework and preliminary assessmentCornea20042375176115502474
- PatelVDWatanabeJHStraussJADubeyATWork productivity loss in patients with dry eye disease: an online surveyCurr Med Res Opin2011271041104821417803
- ShimazakiJTsubotaKKinoshitaSDefinition and diagnosis of dry eye 2006Atarashii Ganka200724181184 Japanese
- GaytonJLEtiology, prevalence, and treatment of dry eye diseaseClin Ophthalmol2009340541219688028
- LeePPWaltJGDoyleJJA multicenter, retrospective pilot study of resource use and costs associated with severity of disease in glaucomaArch Ophthalmol2006124121916401779
- SchmierJKCovertDWRobinALFirst-year treatment costs among new initiators of topical prostaglandin analogsClin Ophthalmol2009363764419997567
- JavittJCCannerJKSommerACost effectiveness of current approaches to the control of retinopathy in type I diabeticsOphthalmology1989962552642495499
- CruessAFZlatevaGXuXEconomic burden of bilateral neovascular age-related macular degeneration: multi-country observational studyPharmacoeconomics200826577318088159